Medlumics is a startup employing biophotonic technologies to develop products that improve human living standards.
Medlumics has raised €56M across 3 funding rounds from 6 investors, most recently a round in Feb 2021. Based in Madrid, Spain; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2021-02-10 | Other | €18M | Asabys Partners | View deal → |
| 2017-03-01 | Series B | €34M | Caixa Capital Risc,Edmond de Rothschild Venture Capital,Innogest Capital,Seroba Life Sciences,Ysios Capital | View deal → |
| 2011-12-01 | Other | €3.5M | Caixa Capital Risc | View deal → |
